Results DPP-4 inhibitors or gliptins are a new class of oral anti-diabetic drugs that seem safe drugs with no severe side effects, commonly GI disturbance, infection and inflammatory bowel disease
As this was a real-world study, we intended to capture the greatest amount of data possible and report findings as a total aggregate by drug class for simplicity
Headaches often: Cause dull, steady pressure or tightness rather than throbbing pain
Developed gastroparesis, ileus, gallbladder disease, vision loss, or blood clot complications
During your first visit, you will receive your first customized weight loss plan
Insulin sensitivity peaks in the morning, and the GIP receptor activation from retatrutide may synergize with this natural morning peak to produce slightly better glucose handling